The University of Strathclyde has opened a £36 million pharmacy and biomedical institute devoted to developing new medicines.
The Glasgow centre employs researchers in chemistry, biology and pharmaceuticals to develop drugs for common diseases such as cancer, heart disease and stroke.
This article on Research Professional News is only available to Research Professional or Pivot-RP users.
Research Professional users can log in and view the article via this link
Pivot-RP users can log in and view the article via this link.